Association of CDX2 expression with clinical, pathologic, and molecular features in MSI-H colorectal cancer

被引：0
|
作者：
Gonzalez, Cyndi
Neyaz, Azfar
Layding, Caroline Jane
Ferrell, Morgan
Giza, Richard
Cheng, Svea
Syed, Masood Pasha
Magge, Tara
Saeed, Anwaar
Tatsuoka, Curtis
Singhi, Aatur D.
Sahin, Ibrahim Halil Halil
机构：
[1] Univ Pittsburgh Med Ctr UPMC, Pittsburgh, PA USA
[2] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15583
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors
    Ziranu, Pina
    Pretta, Andrea
    Pozzari, Marta
    Maccioni, Antonio
    Badiali, Manuela
    Fanni, Daniela
    Lai, Eleonora
    Donisi, Clelia
    Persano, Mara
    Gerosa, Clara
    Puzzoni, Marco
    Bardanzellu, Fabio
    Ambu, Rossano
    Pusceddu, Valeria
    Dubois, Marco
    Cerrone, Giulia
    Migliari, Marco
    Murgia, Sara
    Spanu, Dario
    Pretta, Gianluca
    Aimola, Valentina
    Balconi, Francesca
    Murru, Stefania
    Faa, Gavino
    Scartozzi, Mario
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [2] CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors
    Pina Ziranu
    Andrea Pretta
    Marta Pozzari
    Antonio Maccioni
    Manuela Badiali
    Daniela Fanni
    Eleonora Lai
    Clelia Donisi
    Mara Persano
    Clara Gerosa
    Marco Puzzoni
    Fabio Bardanzellu
    Rossano Ambu
    Valeria Pusceddu
    Marco Dubois
    Giulia Cerrone
    Marco Migliari
    Sara Murgia
    Dario Spanu
    Gianluca Pretta
    Valentina Aimola
    Francesca Balconi
    Stefania Murru
    Gavino Faa
    Mario Scartozzi
    Scientific Reports, 13
  • [3] Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal Cancer
    Baba, Yoshifumi
    Nosho, Katsuhiko
    Shima, Kaori
    Freed, Ellen
    Irahara, Natsumi
    Philips, Juliet
    Meyerhardt, Jeffrey A.
    Hornick, Jason L.
    Shivdasani, Ramesh A.
    Fuchs, Charles S.
    Ogino, Shuji
    CLINICAL CANCER RESEARCH, 2009, 15 (14) : 4665 - 4673
  • [4] Aberrant CDX2 and CK7/CK20 expression in colorectal adenocarcinomas with high-frequency microsatellite instability (MSI-H)
    Chandan, V. S.
    Abraham, S. C.
    Halling, K.
    Wu, T-T
    MODERN PATHOLOGY, 2008, 21 : 114A - 114A
  • [5] Aberrant CDX2 and CK7/CK20 expression in colorectal adenocarcinomas with high-frequency microsatellite instability (MSI-H)
    Chandan, V. S.
    Abraham, S. C.
    Halling, K.
    Wu, T-T
    LABORATORY INVESTIGATION, 2008, 88 : 114A - 114A
  • [6] The clinical perspectives of CDX2 expression in colorectal cancer: A qualitative systematic review
    Olsen, J.
    Espersen, M. L. M.
    Jess, P.
    Kirkeby, L. T.
    Troelsen, J. T.
    SURGICAL ONCOLOGY-OXFORD, 2014, 23 (03): : 167 - 176
  • [7] CDX2 expression between primary and metastatic sites in colorectal cancer in association with chemotherapy
    Shigematsu, Yasuyuki
    Inamura, Kentaro
    Ishikawa, Yuichi
    Kanda, Hiroaki
    CANCER SCIENCE, 2018, 109 : 1347 - 1347
  • [8] Loss of CDX2 expression correlates with clinicopathologic features in colorectal cancers
    Bae, YK
    Choi, JH
    Kim, MJ
    Jung, MG
    MODERN PATHOLOGY, 2005, 18 : 97A - 97A
  • [9] Loss of CDX2 expression correlates with clinicopathologic features in colorectal cancers
    Bae, YK
    Choi, JH
    Kim, MJ
    Jung, MG
    LABORATORY INVESTIGATION, 2005, 85 : 97A - 97A
  • [10] CDX2 polymorphisms, RNA expression, and risk of colorectal cancer
    Rozek, LS
    Lipkin, SM
    Fearon, ER
    Hanash, S
    Giordano, TJ
    Greenson, JK
    Kuick, R
    Misek, DE
    Taylor, JMG
    Douglas, JA
    Rennert, G
    Gruber, SB
    CANCER RESEARCH, 2005, 65 (13) : 5488 - 5492
12345